We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Human Papillomavirus in Menstrual Blood

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01506128
First Posted: January 9, 2012
Last Update Posted: March 5, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Kidong Kim, Seoul National University Bundang Hospital
January 3, 2012
January 9, 2012
March 5, 2013
January 2012
January 2013   (Final data collection date for primary outcome measure)
HPV detection rate in menstrual blood [ Time Frame: First period after enrollment usually within 2 months after enrollment ]
The first menstrual period after enrollment is assumed to occur within 2 months. At that time, the participant used pads and send the used pads to investigators. The investigator do procedures to detect HPV in pads.
Same as current
Complete list of historical versions of study NCT01506128 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Human Papillomavirus in Menstrual Blood
Exploration of Optimal Experimental Settings to Detect Human Papillomavirus From Menstrual Blood in Women With High-grade Squamous Intraepithelial Lesion or High-risk Human Papillomavirus Infection
The investigators tried to know whether a virus causing cervical cancer could be detected in menstrual blood and to set up a experimental setting to detect the virus.
Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:
Menstrual blood in pad
Non-Probability Sample
Premenopausal women with HSIL at Pap test or high-risk HPV
Human Papillomavirus
Other: Collecting a Pad used at the first menstrual period after enrollment
Collecting a Pad used at the first menstrual period after enrollment
HPV
Premenopausal women with HSIL in Pap test or high-risk HPV
Intervention: Other: Collecting a Pad used at the first menstrual period after enrollment
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
19
January 2013
January 2013   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Premenopausal women with HSIL at Pap test or high-risk HPV

Exclusion Criteria:

  • Suspicious cancer
Sexes Eligible for Study: Female
Child, Adult, Senior
No
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
 
 
NCT01506128
SNUBH_GO_001
No
Not Provided
Not Provided
Kidong Kim, Seoul National University Bundang Hospital
Seoul National University Hospital
Not Provided
Not Provided
Seoul National University Hospital
March 2013